6 day(s) ago in category Health
Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this link
Key Market Insights
For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html
Table of Contents
1.2. Scope of the Report
1.3. Research Methodology
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3.1. Chapter Overview
3.2. Introduction to Prefilled Syringes
3.2.1. Classification of Prefilled Syringes
3.2.2. Manufacturing of Prefilled Syringes
3.2.3. Advantages of Prefilled Syringes
3.2.3.1. Benefits to Healthcare Professionals and End Users
3.2.3.2. Benefits to Manufacturers
3.3. Fill / Finish Processing of Prefilled Syringes
3.3.1. Steps Involved in Fill / Finish Process
3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
3.3.3. Prefilled Syringe Filling Technologies
3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
3.6. Advantages of Outsourcing Fill / Finish Services
3.7. Risks Associated with Outsourcing of Fill / Finish Operations
3.8. Key Considerations While Selecting a Fill / Finish Service Provider
4.1. Chapter Overview
4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Scale of Operation
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
4.2.6. Analysis by Type of Drug Molecule
4.2.7. Analysis by Syringe Barrel Material
4.2.8. Analysis by Syringe Fill Volume
4.2.9. Analysis by Additional Services Offered
4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Recent Developments and Future Outlook
5.3. AMRI
5.3.1. Company Overview
5.3.2. Recent Developments and Future Outlook
5.4. BioPharma Solutions
5.4.1. Company Overview
5.4.2. Recent Developments and Future Outlook
5.5. Emergent BioSolutions
5.5.1. Company Overview
5.5.2. Recent Developments and Future Outlook
5.6. Patheon (a Thermo Fisher Scientific Company)
5.6.1. Company Overview
5.6.2. Recent Developments and Future Outlook
6.1. Chapter Overview
6.2. Consort Medical
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. EVER Pharma
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. GlaxoSmithKline
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. IDT Biologika
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. Rentschler Biopharma
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Siegfried
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Vetter Pharma
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
7.1. Chapter Overview
7.2. Biocon
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. Intas Pharmaceuticals
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. Kemwell Biopharma
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Square Pharmaceuticals
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
8.1. Chapter Overview
8.2. List of Expansions
8.2.1. Analysis by Year of Expansion
8.2.2. Analysis by Type of Expansion
8.2.3. Analysis by Expanded Scale of Operation
8.2.4. Analysis by Location of Expansion Project
8.2.5. Analysis by Type of Drug Molecule Involved
8.2.6. Analysis by Additional Services Offered (Expansion Specific)
8.3. Partnership Models
8.4. List of Partnerships and Collaborations
8.4.1. Analysis by Year of Partnership
8.4.2. Analysis by Type of Partnership
8.4.3. Analysis by Scale of Operation (Deal Specific)
8.4.4. Analysis by Additional Services Offered (Deal Specific)
9.1. Chapter Overview
9.2. Assumptions and Methodology
9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1. Analysis by Company Size
9.3.2. Analysis by Scale of Operation
9.3.3. Analysis by Location of Headquarters
9.3.4. Analysis by Location of Fill / Finish Facilities
9.3.5. Analysis by Type of Drug Molecule
9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
9.4.1. Analysis by Company Size (Manufacturer)
9.4.2. Analysis by Scale of Operation
9.4.3. Analysis by Location of Headquarters
9.4.4. Analysis by Location of Fill / Finish Facilities
9.4.5. Analysis by Type of Drug Molecule
10.1. Chapter Overview
10.2. Assumptions and Methodology
10.3. Global Demand for Prefilled Syringes Fill / Finish Services
10.3.1. Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2. Global Demand for Clinical Prefilled Syringes Fill / Finish Services
10.4. Demand and Supply Analysis
10.4.1. Demand and Supply Analysis (Scenario 1)
10.4.2. Demand and Supply Analysis (Scenario 2)
10.4.3. Demand and Supply Analysis (Scenario 3)
11.1. Chapter Overview
11.2. Assumptions and Key Parameters
11.3. Demand and Supply Assessment in North America
11.3.1. Key Geographies
11.3.1.1. US
11.4. Demand and Supply Assessment in Europe
11.4.1. Key Geographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5. Demand and Supply Assessment in Asia-Pacific Region
11.5.1. Key Geographies
11.5.1.1. India
11.5.1.2. Japan
12.1. Chapter Overview
12.2. Methodology and Key Parameters
12.3. Likely Partner Analysis
12.3.1. Opportunities in North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2. Opportunities in Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3. Opportunities in Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Prefilled Syringe Fill / Finish Services Market, 2020-2030
13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, 2020-2030
13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, 2020-2030
13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, 2020-2030
13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, 2020-2030
14.1. Chapter Overview
14.2. Growing Injectable Drugs Pipeline
14.3. Increase in Popularity of Prefilled Syringes
14.4. Rise in Preference for Outsourcing Fill / Finish Activities
14.5. Advances in Aseptic Fill / Finish Technologies
14.6. Growing Opportunities in the Asia-Pacific Region
15.1. Chapter Overview
15.2. Prefilled Syringes: List of Available / Under Development Devices
15.2.1. Analysis by Syringe Barrel Material
15.2.2. Analysis by Number of Barrel Chambers
15.2.3. Analysis by Type of Needle System
15.2.4. Analysis by Barrel Volume
15.3. Prefilled Syringes: List of Manufacturers
15.3.1. Analysis by Year of Establishment
15.3.2. Analysis by Location of Headquarters
16.1. Chapter Overview
16.2. Key Takeaways
17.1. Chapter Overview
17.2. Bio Elpida
17.2.1. Company Snapshot
17.2.2. Interview Transcript: Gilles Devillers, President and Cofounder
17.3. Intas Pharmaceuticals
17.3.1. Company Snapshot
17.3.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer
17.4. IDT Biologika
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
17.5. Takeda
17.5.1. Company Snapshot
17.5.2. Interview Transcript: Michael Dekner, Associate Director, Head of Process Sciences Formulation and Fill / Finish
17.6. Synegene
17.6.1. Company Snapshot
17.6.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
17.7. IDEO
17.7.1. Company Snapshot
17.7.2. Interview Transcript: Jesse Fourt, Design Director
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
To order this detailed 290+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules, ..
Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated ..
Roots Analysis has done a detailed study on “ In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), ..
Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery ..
Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate ..
To order this detailed 235+ page report, please visit this link Key Inclusions An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status ..
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices ..
Roots Analysis has done a detailed study on “ Global Handheld Ultrasound Imaging Devices Market, 2020-2030 ” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. ..
Roots Analysis has done a detailed study on “ Global Handheld Ultrasound Imaging Devices Market, 2020-2030 ” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. ..
Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution ..
If you are new in order to the field of blogging, an individual are not by yourself. Just simply a few years before, the term didn't even occur. Right now, it has come to be a standard feature associated ..
Leaflet circulation is one of the earliest methods of marketing used. https://www.google.com/maps?cid=4815603585143824521 of companies having actually been using it since a long time. Also in this electronic ..
Również Suzuki występuje na regule tych pojazdów do końca sztuk i hamuje silnik. Aktualnie on ogólne samochodach Volkswagen Ford Bentley BMW Volvo jak również Wiązanie i składanie lusterek. Oczywiście ..
Portal de información, análisis y opinión sobre el poder en Colombia https://newmoviz21.tumblr.com/post/640700377035145216/r6uyrynrt-erdneue5srs https://www.deviantart.com/etha404/journal/What-Next-Adweeks-2021-Outlook-for-Media-Market-867554984 ..
https://pietrobon-kaeltetechnik.ch/kaeltemaschinen/ : Kälteerzeugung mit Kältemaschinen Die geschichtliche Fortentwicklung der Kälteerzeugung geht in von den physikalischen und chemischen Laboratorien. ..
https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/AXT1725-true-free-v-bucks-new-updated-vbucks-generator.pdf https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/AXT1725-free-fortnite-v-bucks-generator-nod.pdf ..
https://expo.io/@avakin-life-avacoins-generator-no-human-verification https://expo.io/@free-dragon-ball-legends-chrono-crystals https://expo.io/@steam-wallet-gift-card-generator-no-verification https://expo.io/@free-candy-crush-saga-gold-generator ..
https://expo.io/@avakin-life-avacoins-generator-no-human-verification https://expo.io/@free-dragon-ball-legends-chrono-crystals https://expo.io/@steam-wallet-gift-card-generator-no-verification https://expo.io/@free-candy-crush-saga-gold-generator ..
https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-free-robux-generator.pdf https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-free-robux-Roblox-generator.pdf https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-robux-free-generator-updated-new.pdf ..
https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-free-robux-generator.pdf https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-free-robux-Roblox-generator.pdf https://content-calpoly-edu.s3.amazonaws.com/english/1/webform/B45tY-robux-free-generator-updated-new.pdf ..
The Los Angeles County Board of Supervisors considers more infection-control, including possible closures ..
Many teachers, grocers and even some hospital employees are wary of the COVID-19 vaccine and don’t want ..
How widespread is the UK variant in the US? CDC report projects UK variant will be the predominant strain ..
DNA evidence shows that the now famous -- and extinct -- dire wolf species couldn't mate with gray wolves. ..
While NASA previously determined that there were around two trillion galaxies in the universe, new findings ..
NASA's Curiosity rover marked 3,000 Martian days, or "sols," on the Red Planet Tuesday (Jan. 12), a mere ..
NASA's Orion spacecraft is complete and ready for its Artemis I test mission to the Moon later in 2021. ..
Olympic sailing champion Sofia Bekatorou of Greece has accused an unnamed sporting official of sexually ..
Here's what's buzzing around MLB for Friday
Bucs running back Leonard Fournette will start in place of Ronald Jones, who missed last week's wild-card ..
